Edward van der Horst
Director Técnico/Científico/I+D en SENSEI BIOTHERAPEUTICS, INC. .
Fortuna: 56 070 $ al 30/04/2024
Perfil
Edward van der Horst is currently the Chief Scientific Officer at Sensei Biotherapeutics, Inc. He previously worked as the Senior Director-Preclinical Development at Igenica Biotherapeutics, Inc. from 2010 to 2017 and as the VP-Discovery Biology & Preclinical Drug at Zenith Epigenetics Ltd.
from 2017 to 2019.
Dr. van der Horst obtained a graduate degree from Ludwig-Maximilians-Universität München and a doctorate degree from Max Planck Institute of Biochemistry.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/02/2024 | 56 070 ( 0.22% ) | 56 070 $ | 30/04/2024 |
Cargos activos de Edward van der Horst
| Empresas | Cargo | Inicio |
|---|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Director Técnico/Científico/I+D | 07/12/2022 |
Antiguos cargos conocidos de Edward van der Horst.
| Empresas | Cargo | Fin |
|---|---|---|
Zenith Epigenetics Ltd.
 Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Corporate Officer/Principal | 01/08/2019 |
Igenica Biotherapeutics, Inc.
 Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Corporate Officer/Principal | 01/01/2017 |
Formación de Edward van der Horst.
| Max Planck Institute of Biochemistry | Doctorate Degree |
| Ludwig-Maximilians-Universität München | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SENSEI BIOTHERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Zenith Epigenetics Ltd.
Zenith Epigenetics Ltd. Miscellaneous Commercial ServicesCommercial Services Zenith Epigenetics Ltd. operates as a Canadian clinical-stage biotechnology company. The private company is based in Calgary, Canada. | Commercial Services |
Igenica Biotherapeutics, Inc.
Igenica Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Igenica Biotherapeutics, Inc. develops therapeutics for the treatment of cancer. It develops antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. The firm offers recombinant monoclonal antibodies for oncology and cancer treatment. The company was founded by Robert Schreiber and Guoqing Chen in 2008 and is headquartered in Burlingame, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Edward van der Horst
